ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca.
In a society where acceptance remains elusive for many, the Special Children Center Group Home Texas stands as a crucial lifeline for transgender youths and adults. This initiative doesn't just ...
A recent report by the US Geological Survey (USGS) shows that much of Connecticut’s public groundwater supply areas, including areas that provide water to the state's largest cities, have a high ...